ACR适宜性标准:胰腺神经内分泌肿瘤的分期与随访
该指南为胰腺神经内分泌肿瘤患者提供六种临床情景下的影像学评估推荐:增强CT在多数情景下通常适用且常作为一线影像方法;MRI通常适用,尤其用于肝脏评估;DOTATATE PET/CT通常适用于疑似或已知转移性疾病的分期与治疗计划;FDG-PET/CT仅用于高分级肿瘤等特定病例。
要点
- 增强CT在大多数胰腺神经内分泌肿瘤情景下通常适用,常作为一线影像方法评估肿瘤大小、局部范围、血管侵犯和转移。
- MRI通常适用,尤其用于肝脏评估;肝胆对比剂增强MRI和扩散加权成像可提高肝转移灶的检出和表征。
- DOTATATE PET/CT通常适用于疑似或已知转移性疾病的分期和治疗计划;FDG-PET/CT仅用于高分级肿瘤等特定病例。
核心结论
- 增强CT在多数胰腺神经内分泌肿瘤情景下通常适用且常作为一线影像方法;MRI通常适用尤其用于肝脏评估;DOTATATE PET/CT通常适用于疑似或已知转移性疾病的分期与治疗计划;FDG-PET/CT仅用于高分级肿瘤等特定病例。
研究设计与样本
- 美国放射学会适宜性标准基于证据的指南,由多学科专家小组每年审查,采用GRADE等既定方法学原则评估证据,采用RAND/UCLA适宜性方法学确定影像和治疗的适宜性;针对六个临床情景:局部 staging、转移性疾病分期、切除后监测、肝优势疾病治疗后随访、非肝优势疾病治疗后随访、未治疗疾病随访。
诊断标准与关键数值
- 增强CT在大多数情景下通常适用,常作为一线影像方法评估肿瘤大小、局部范围、血管侵犯和转移。
- MRI通常适用,尤其用于肝脏评估;肝胆对比剂增强MRI和扩散加权成像可提高肝转移灶的检出和表征,尤其在肝优势疾病中。
- DOTATATE PET/CT通常适用于疑似或已知转移性疾病患者的分期和治疗计划。
- FDG-PET/CT仅用于特定病例,如高分级肿瘤。
临床应用与阅片要点
- 对胰腺神经内分泌肿瘤患者,增强CT在多数临床情景下通常适用,可作为一线影像方法评估肿瘤大小、局部范围、血管侵犯和转移。
- MRI通常适用,尤其用于肝脏评估;肝胆对比剂增强MRI和扩散加权成像可提高肝转移灶的检出和表征,尤其在肝优势疾病中。
- 疑似或已知转移性疾病患者的分期和治疗计划中,DOTATATE PET/CT通常适用。
- FDG-PET/CT仅用于特定病例,如高分级肿瘤。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Accurate staging and appropriate follow-up imaging of pancreatic neuroendocrine tumors (PNET) are essential for guiding management and optimizing outcomes. This document provides evidence-based recommendations for the imaging evaluation of patients with PNET across six clinical variants: local staging, staging for metastatic disease, surveillance postresection, follow-up after treatment of liver-dominant and non-liver dominant disease, and follow-up of untreated disease. Contrast-enhanced CT is usually appropriate in most scenarios and commonly used as the first-line imaging modality in assessing tumor size, locoregional extent, vascular involvement, and metastatic spread. MRI is also usually appropriate, particularly for liver evaluation. MRI with hepatobiliary contrast agents and diffusion-weighted imaging improves detection and characterization of liver metastases, especially in liver-dominant disease. DOTATATE PET/CT is usually appropriate for staging and treatment planning in patients with suspected or known metastatic disease. FDG-PET/CT is reserved for select cases, such as high-grade tumors. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer-reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Yacoub JH, Yano M, Chang KJ, et al. ACR Appropriateness Criteria® Staging and Follow-Up of Pancreatic Neuroendocrine Tumors. J Am Coll Radiol. 2026. PMID: 41823937. doi:10.1016/j.jacr.2026.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。